| Azerbaigian | Turchia | Austria | |
| Trapianto di midollo osseo allogenico da donatore non correlato | - | da $80,000 | da $180,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | - | da $65,000 | da $150,000 |
| Trapianto di midollo osseo | - | da $36,000 | da $140,000 |
| Terapia con cellule CAR-T | - | da $150,000 | da $350,000 |
| Terapia biologica | - | da $5,500 | da $20,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Ematologia Oncologia. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Ematologia Oncologia e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento di procedure di Ematologia Oncologia.
Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.
Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.
Patients receiving hematology-oncology treatments in Azerbaijan may experience short-term side effects like hair loss and fatigue. Long-term risks include peripheral neuropathy and cognitive changes. Accredited centers like Liv Bona Dea Hospital Baku or the National Center of Oncology provide multidisciplinary support to manage these concerns.
Bookimed Expert Insight: Liv Bona Dea Hospital Baku serves 200,000 patients yearly and was ranked by Bookimed for excellence in blood disorders and cancer treatment in 2019. This high patient volume allows specialist doctors like Dr. Selime Aydogdu and Tural Pashayev to refine supportive care protocols for complex conditions like leukemia and myeloma. Patients should prioritize JCI-accredited facilities in Baku to ensure international safety standards for managing treatment toxicity.
Patient Consensus: Patients note that fatigue is often more intense than expected and not easily relieved by rest. They also emphasize that neuropathy and memory issues can persist long after treatment ends, making early discussions about these risks essential.